Effect of crizotinib on overall survival in patients with advanced non-small-cell lung cancer harbouring ALK gene rearrangement: a retrospective analysis

Схожі ресурси

• Effect of crizotinib on overall survival in patients with advanced non-small-cell lung cancer harbouring ALK gene rearrangement: a retrospective analysis
  за авторством: Shaw, Alice T, та інші
  Опубліковано: (2011)
• Activity and safety of crizotinib in patients with ALK-positive non-small-cell lung cancer: updated results from a phase 1 study
  за авторством: D. Ross Camidge, та інші
  Опубліковано: (2012)
• Activity and safety of crizotinib in patients with ALK-positive non-small-cell lung cancer: updated results from a phase 1 study
  за авторством: Camidge, D Ross, та інші
  Опубліковано: (2012)
• Rapid and Dramatic Radiographic and Clinical Response to an ALK Inhibitor (Crizotinib, PF02341066) in an ALK Translocation-Positive Patient with Non-small Cell Lung Cancer
  за авторством: Sai‐Hong Ignatius Ou, та інші
  Опубліковано: (2010)
• Correlations between the percentage of tumor cells showing an ALK gene rearrangement, ALK signal copy number and response to crizotinib therapy in ALK FISH positive non-small cell lung cancer
  за авторством: Camidge, D. Ross, та інші
  Опубліковано: (2012)